203 related articles for article (PubMed ID: 9933597)
1. Hydrolysis of peptide hormones by endothelin-converting enzyme-1. A comparison with neprilysin.
Johnson GD; Stevenson T; Ahn K
J Biol Chem; 1999 Feb; 274(7):4053-8. PubMed ID: 9933597
[TBL] [Abstract][Full Text] [Related]
2. Mapping the active site of endothelin-converting enzyme-1 through subsite specificity and mutagenesis studies: a comparison with neprilysin.
Johnson GD; Swenson HR; Ramage R; Ahn K
Arch Biochem Biophys; 2002 Feb; 398(2):240-8. PubMed ID: 11831855
[TBL] [Abstract][Full Text] [Related]
3. Development of an internally quenched fluorescent substrate selective for endothelin-converting enzyme-1.
Johnson GD; Ahn K
Anal Biochem; 2000 Nov; 286(1):112-8. PubMed ID: 11038281
[TBL] [Abstract][Full Text] [Related]
4. Endothelin-converting enzyme-2 is a membrane-bound, phosphoramidon-sensitive metalloprotease with acidic pH optimum.
Emoto N; Yanagisawa M
J Biol Chem; 1995 Jun; 270(25):15262-8. PubMed ID: 7797512
[TBL] [Abstract][Full Text] [Related]
5. Molecular pharmacology of endothelin converting enzymes.
Turner AJ; Murphy LJ
Biochem Pharmacol; 1996 Jan; 51(2):91-102. PubMed ID: 8615890
[TBL] [Abstract][Full Text] [Related]
6. Novel activity of endothelin-converting enzyme: hydrolysis of bradykinin.
Hoang MV; Turner AJ
Biochem J; 1997 Oct; 327 ( Pt 1)(Pt 1):23-6. PubMed ID: 9355729
[TBL] [Abstract][Full Text] [Related]
7. Disulfide bonds in big ET-1 are essential for the specific cleavage at the Trp(21)-Val(22) bond by soluble endothelin converting enzyme-1 from baculovirus/insect cells.
Fahnoe DC; Johnson GD; Herman SB; Ahn K
Arch Biochem Biophys; 2000 Jan; 373(2):385-93. PubMed ID: 10620363
[TBL] [Abstract][Full Text] [Related]
8. Big endothelin analogues with inhibitory activity on endothelin-converting enzyme-1.
Takayanagi R; Liu W; Ito T; Ohnaka K; Nawata H
J Cardiovasc Pharmacol; 1998; 31 Suppl 1():S62-3. PubMed ID: 9595401
[TBL] [Abstract][Full Text] [Related]
9. Physiological relevance of hydrolysis of atrial natriuretic peptide by endothelin-converting enzyme-1.
Nakayama K; Emoto N; Suzuki Y; Vignon-Zellweger N; Yagi K; Hirata K
Kobe J Med Sci; 2012 Jun; 58(1):E12-8. PubMed ID: 22972025
[TBL] [Abstract][Full Text] [Related]
10. Mutagenesis of Glu403 to Cys in rabbit neutral endopeptidase-24.11 (neprilysin) creates a disulphide-linked homodimer: analogy with endothelin-converting enzyme.
Hoang MV; Sansom CE; Turner AJ
Biochem J; 1997 Nov; 327 ( Pt 3)(Pt 3):925-9. PubMed ID: 9581575
[TBL] [Abstract][Full Text] [Related]
11. Characterization of endothelin-converting enzyme-2. Implication for a role in the nonclassical processing of regulatory peptides.
Mzhavia N; Pan H; Che FY; Fricker LD; Devi LA
J Biol Chem; 2003 Apr; 278(17):14704-11. PubMed ID: 12560336
[TBL] [Abstract][Full Text] [Related]
12. Recombinant human endothelin-converting enzyme ECE-1b is located in an intracellular compartment when expressed in polarized Madin-Darby canine kidney cells.
Azarani A; Boileau G; Crine P
Biochem J; 1998 Jul; 333 ( Pt 2)(Pt 2):439-48. PubMed ID: 9657986
[TBL] [Abstract][Full Text] [Related]
13. The N-terminal segment of endothelin-converting enzyme (ECE)-1b contains a di-leucine motif that can redirect neprilysin to an intracellular compartment in Madin-Darby canine kidney (MDCK) cells.
Cailler F; Zappulla JP; Boileau G; Crine P
Biochem J; 1999 Jul; 341 ( Pt 1)(Pt 1):119-26. PubMed ID: 10377252
[TBL] [Abstract][Full Text] [Related]
14. Rat endothelin-converting enzyme-1 forms a dimer through Cys412 with a similar catalytic mechanism and a distinct substrate binding mechanism compared with neutral endopeptidase-24.11.
Shimada K; Takahashi M; Turner AJ; Tanzawa K
Biochem J; 1996 May; 315 ( Pt 3)(Pt 3):863-7. PubMed ID: 8645169
[TBL] [Abstract][Full Text] [Related]
15. Soluble human endothelin-converting enzyme-1: expression, purification, and demonstration of pronounced pH sensitivity.
Ahn K; Herman SB; Fahnoe DC
Arch Biochem Biophys; 1998 Nov; 359(2):258-68. PubMed ID: 9808768
[TBL] [Abstract][Full Text] [Related]
16. Construction, expression and characterization of a soluble form of human endothelin-converting-enzyme-1.
Korth P; Egidy G; Parnot C; LeMoullec JM; Corvol P; Pinet F
FEBS Lett; 1997 Nov; 417(3):365-70. PubMed ID: 9409753
[TBL] [Abstract][Full Text] [Related]
17. The endothelin system and endothelin-converting enzyme in the brain: molecular and cellular studies.
Barnes K; Turner AJ
Neurochem Res; 1997 Aug; 22(8):1033-40. PubMed ID: 9239759
[TBL] [Abstract][Full Text] [Related]
18. Structure of human endothelin-converting enzyme I complexed with phosphoramidon.
Schulz H; Dale GE; Karimi-Nejad Y; Oefner C
J Mol Biol; 2009 Jan; 385(1):178-87. PubMed ID: 18992253
[TBL] [Abstract][Full Text] [Related]
19. Secretion of endothelin converting enzyme-1a: the hydrophobic signal anchor domain alone is not sufficient to promote membrane localization.
Brooks SC; Fernandez L; Ergul A
Mol Cell Biochem; 2000 May; 208(1-2):45-51. PubMed ID: 10939627
[TBL] [Abstract][Full Text] [Related]
20. Inhibitor potencies and substrate preference for endothelin-converting enzyme-1 are dramatically affected by pH.
Fahnoe DC; Knapp J; Johnson GD; Ahn K
J Cardiovasc Pharmacol; 2000 Nov; 36(5 Suppl 1):S22-5. PubMed ID: 11078325
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
